Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion description "[These results suggested that over-expression and activity of PKC? is closely associated with the regulation of the MDR phenotype in human colon cancer HCT15 cells and provided insight into a new strategy for inhibiting doxorubicin resistance in human cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion evidence source_evidence_literature NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion SIO_000772 22639047 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion wasDerivedFrom befree-20150227 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion wasGeneratedBy ECO_0000203 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.